0001104659-21-147273.txt : 20211207
0001104659-21-147273.hdr.sgml : 20211207
20211207171631
ACCESSION NUMBER: 0001104659-21-147273
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211206
FILED AS OF DATE: 20211207
DATE AS OF CHANGE: 20211207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kruse Bo
CENTRAL INDEX KEY: 0001752940
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 211476826
MAIL ADDRESS:
STREET 1: C/O Y-MABS THERAPEUTICS, INC.
STREET 2: 230 PARK AVENUE, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10169
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
4
1
tm2134789-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-12-06
0
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001752940
Kruse Bo
C/O Y-MABS THERAPEUTICS, INC.
230 PARK AVENUE SUITE 3350
NEW YORK
NY
10169
0
1
0
0
EVP, CFO, Secretary & Treas.
Common Stock
2021-12-06
4
S
0
4000
16.35
D
201077
D
Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2021.
/s/ Bo Kruse
2021-12-07